Peripheral Vascular Diagnostic Systems

Global Peripheral Vascular Diagnostic Systems Market to Reach US$640.2 Million by 2030

The global market for Peripheral Vascular Diagnostic Systems estimated at US$447.3 Million in the year 2024, is expected to reach US$640.2 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$378.9 Million by the end of the analysis period. Growth in the Ambulatory Surgery Centers End-Use segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$121.9 Million While China is Forecast to Grow at 9.6% CAGR

The Peripheral Vascular Diagnostic Systems market in the U.S. is estimated at US$121.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$130.4 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Peripheral Vascular Diagnostic Systems Market - Key Trends & Drivers Summarized

Why Are Peripheral Vascular Diagnostic Systems Becoming Central to Vascular Disease Management?

Peripheral vascular diagnostic systems are used to detect and assess disorders in arteries and veins located outside the heart and brain. These systems help diagnose peripheral artery disease (PAD), chronic venous insufficiency, deep vein thrombosis, and aneurysms. As the global burden of vascular disease increases due to diabetes, smoking, and sedentary lifestyles, accurate and early diagnosis has become essential to prevent complications such as limb ischemia or stroke.

These systems typically include Doppler ultrasound, ankle-brachial index (ABI) measurement tools, plethysmography, and advanced imaging modalities. Integration into outpatient clinics, vascular labs, and primary care facilities is improving accessibility and enabling more routine screening. Growing recognition of PAD as an early marker of systemic atherosclerosis is increasing the role of vascular diagnostics in preventive cardiology as well.

How Are Technology Advancements Enhancing Accuracy and Clinical Usefulness?

Non-invasive diagnostic systems now offer faster, more accurate results with improved sensitivity for early-stage disease. Portable Doppler ultrasound systems with high-resolution probes, automated ABI measurement devices, and real-time blood flow monitoring tools are allowing quicker assessments with minimal patient discomfort. Integration of artificial intelligence into imaging platforms is helping clinicians interpret results more efficiently and reduce diagnostic variability.

Multimodal diagnostic units that combine ABI, pulse volume recording, and duplex ultrasound are being developed to offer comprehensive assessments in a single session. In advanced care centers, digital vascular imaging systems provide functional and anatomical information, assisting in pre-procedural planning. Telemedicine-compatible devices and cloud-based diagnostic platforms are emerging to support remote patient assessment, especially in underserved regions.

Where Is Adoption Expanding and Which Facilities Are Driving Demand?

Diagnostic systems are widely used in vascular surgery centers, outpatient clinics, and cardiology departments. Primary care physicians are also adopting basic ABI screening tools to identify at-risk patients early. North America and Europe lead in deployment, aided by established reimbursement structures and public health screening programs. Asia-Pacific is seeing increasing usage due to the rise in lifestyle-related vascular diseases and expansion of specialty diagnostic centers.

Hospitals are investing in portable vascular diagnostic tools to streamline emergency evaluations and pre-operative risk assessments. In ambulatory and community care settings, portable ABI systems are being used for rapid PAD screening. As awareness grows among general practitioners and endocrinologists about vascular complications in diabetic patients, demand for diagnostic solutions is expanding in both urban and rural settings.

Growth in the Peripheral Vascular Diagnostic Systems market is driven by several factors…

Growth in the peripheral vascular diagnostic systems market is driven by factors such as increasing prevalence of peripheral vascular disorders, technological advancements in non-invasive diagnostic tools, and expanding screening initiatives for at-risk populations. Rising diabetic and elderly populations are prompting regular use of ABI and Doppler-based assessments in preventive care.

Development of portable, user-friendly diagnostic devices, integration of AI-driven imaging analysis, and growing emphasis on early intervention are supporting market adoption. Improved awareness among primary care providers, combined with investment in outpatient diagnostic infrastructure and digital health platforms, is helping expand access to vascular diagnostics globally.

SCOPE OF STUDY:

The report analyzes the Peripheral Vascular Diagnostic Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Physician Office End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott
• ADInstruments
• AngioDynamics
• B. Braun Melsungen AG
• Biopac Systems Inc.
• Canon Medical Systems Corp
• Carestream Health
• Compumedics Limited
• Cook Medical
• ELCAT GmbH
• Fukuda Denshi Co., Ltd.
• GE HealthCare
• Hitachi Medical Systems
• KONINKLIJKE PHILIPS N.V.
• Medtronic
• MESI, Ltd.
• Mindray Medical International
• Natus Medical Incorporated
• Siemens Healthineers
• Vaso Corporation

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.